US Patent Issued to GUANGZHOU OCUSUN OPTHALMIC BIOTECHNOLOGY on Nov. 4 for "Isoquinolinone derivatives serving as rock protein kinase inhibitors and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,918, issued on Nov. 4, was assigned to GUANGZHOU OCUSUN OPTHALMIC BIOTECHNOLOGY Co. LTD. (Guangzhou, China).

"Isoquinolinone derivatives serving as rock protein kinase inhibitors and use thereof" was invented by Yizhi Liu (Guangzhou, China), Yandong Wang (Guangzhou, China), Lingyun Wu (Guangzhou, China), Xu You (Guangzhou, China), Zheming Xiao (Guangzhou, China) and Shuhui Chen (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a series of isoquinolone derivatives as ROCK protein kinase inhibitors and uses thereof in preparing medicaments for ROCK protein kinase inhibitor-related glaucoma or ocular hypertension diseases. S...